Nitrostat and Humulin n drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitrostat (nitroglycerin) and Humulin n (insulin susp isophane recombinant human). Common drug interactions include cardiac failure congestive among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Nitrostat and Humulin n. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.

What is Humulin n?

Humulin n has active ingredients of insulin susp isophane recombinant human. It is often used in diabetes. eHealthMe is studying from 9,878 Humulin n users. Check the latest studies of Humulin n.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

26 people who take Nitrostat and Humulin n together, and have interactions are studied.

Nitrostat and Humulin n drug interactions.

What are the common drug interactions of Nitrostat and Humulin N, by gender? *:

female:

  1. Cardiac failure congestive
  2. Dyspnoea (difficult or laboured respiration)
  3. Arrhythmia (irregular heartbeat)
  4. Blood glucose decreased
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Cough
  7. Diarrhoea
  8. Drug ineffective
  9. Dry mouth
  10. Heart injury

male:

  1. Rash
  2. Nausea (feeling of having an urge to vomit)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Asthenia (weakness)
  5. Atrioventricular block (heart block)
  6. Bradycardia (abnormally slow heart action)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cardiac failure
  9. Drug hypersensitivity
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Nitrostat and Humulin N, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Rash
  2. Atrioventricular block second degree (heart block second degree)
  3. Hypertension (high blood pressure)
  4. Lung infection
  5. Nausea (feeling of having an urge to vomit)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Pneumonia
  8. Pyelonephritis (inflammation of kidney caused by bacteria)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Asthenia (weakness)

50-59:

  1. Arrhythmia (irregular heartbeat)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Cardiac failure congestive
  4. Cough
  5. Heart injury
  6. Lower respiratory tract infection
  7. Pulmonary congestion (congestion in the lungs)
  8. Pulmonary oedema (fluid accumulation in the lungs)
  9. Sedation
  10. Ventricular extrasystoles (premature cardiac contraction)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Blood glucose increased
  3. Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
  4. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  5. Abdominal discomfort
  6. Anaemia (lack of blood)
  7. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  8. Atrioventricular block (heart block)
  9. Bradycardia (abnormally slow heart action)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Pain: 7 people, 26.92%
  2. Stable Angina (a constant chest pain): 5 people, 19.23%
  3. Neuropathy Peripheral (surface nerve damage): 5 people, 19.23%
  4. High Blood Cholesterol: 5 people, 19.23%
  5. High Blood Pressure: 5 people, 19.23%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 15.38%
  7. Nausea (feeling of having an urge to vomit): 3 people, 11.54%
  8. Depression: 3 people, 11.54%
  9. Dizziness: 3 people, 11.54%
  10. Cardiac Disorder: 3 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrostat and Humulin n?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nitrostat and Humulin n:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nitrostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Humulin n:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrostat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humulin n and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin and insulin susp isophane recombinant human (the active ingredients of Nitrostat and Humulin n, respectively), and Nitrostat and Humulin n (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: